Understanding the response of dendritic cells to activation by streptococcal preparation OK-432

Anticancer Research

Volumn 25, Issue 6 B, 2005, Pages 4231-4238

  Kanzaki, Norio ^a   Terashima, Masanori ^a   Kashimura, Seigo ^a   Hoshino, Mika ^a   Ohtani, Satoshi ^a   Matsuyama, Shinichi ^a   Hoshino, Yutaka ^a   Kogure, Michihiko ^a   Oshibe, Ikurou ^a   Endo, Hisahito ^a   Saito, Takahiro ^a   Yaginuma, Hiroshi ^a   Gotoh, Mitsukazu ^a   Ohto, Hitoshi ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Dendritic cells; OK 432; TLR 4; Toll like receptor; Tumor immunity

Indexed keywords

MESSENGER RNA; PICIBANIL; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY DETECTION; ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVATION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; DRUG CYTOTOXICITY; EFFECTOR CELL; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STREPTOCOCCUS; TARGET CELL;

ADULT; CELL LINE, TUMOR; CYTOKINES; DENDRITIC CELLS; HUMANS; LEUKOCYTES, MONONUCLEAR; PICIBANIL; RNA, MESSENGER; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 27944487443     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Steinman RM, Lustig DS and Cohn ZA: Identification of a novel cell type in peripheral lymphoid organs of mice. 3. Functional properties in vivo. J Exp Med 139: 1431-1445, 1974.
2. Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9: 271-296, 1991.
3. Inaba K, Steinman RM, Pack MW, Pack MW, Aya H, Inaba M, Sudo T, Wolpe S and Schuler G: Identification of proliferating dendritic cell precursors in mouse blood. J Exp Med 175: 1157-1167, 1992.
4. Stift A, Friedl J, Dubsky P, Bachleitner-Hofmann T, Schueller G, Zontsich T, Benkoe T, Radelbauer K, Brostjan C, Jakesz R and Gnant M: Dendritic cell-based vaccination in solid cancer. J Clin Oncol 21: 135-142, 2003.
5. Thurner B, Haendle I, Roder C, Dieckmann D, Keikavoussi P, Jonuleit H, Bender A, Maczek C, Schreiner D, Driesch P, Brocker EB, Steinman RM, Enk A, Kampgen E and Schuler G: Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med 190: 1669-1678, 1999.
6. Dhodapkar MV, Steinman RM, Krasovsky J, Munz C and Bhardwaj N: Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 193: 233-238, 2001.
7. Romani N, Reider D, Heuer M, Kampgen E, Eibl B, Niederwieser D and Schuler G: Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods 196: 137-151, 1996.
8. Verdijk RM, Mutis T, Esendam B, Kamp J, Melief CJM, Brand A and Goulmy E: Polyriboinosinic polyribocytidylic acid (Poly(I:C)) induces stable maturation of functionally active human dendritic cells. J Immunol 163: 57-61, 1999.
9. Banchereau J and Steinman RM: Dendritic cells and the control of immunity. Nature 392: 245-252, 1998.
10. Caux C, Dezutter-Dambuyant C, Schmitt D and Banchereau J: GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 360: 258-261, 1992.
11. Jonuleit H, Kuhn U, Muller G, Steinbrink K, Paragnik L, Schmitt E, Knop J and Enk AH: Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 27: 3135-3142, 1997.
12. Fujimoto T, Duda RB, Szilvasi A, Szilvasi A, Chen X, Mai M and O'Donnell MA: Streptoccocal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant state. J Immunol 158: 5619-5626, 1997.
13. Tamada K, Harada M, Abe K, Li T, Tada H, Onoe Y and Nomoto K: Antitumor vaccination effect of dendritic cells can be augmented by locally utilizing Th1-type cytokines from OK432-reactive CD4+ T cells. Cancer Immunol Immunother 46: 128-136, 1998.
14. Toyokawa H, Inaba M, Takai S, Satoi S, Beuth J, Ko HL, Matsui Y, Kwon AH, Kamiyama Y and Ikehara S: Enhancement of circulating dendritic cell activity by immunomodulators (OK432 and KP-40). Anticancer Res 22: 2137-2145, 2002.
15. Itoh T, Ueda Y, Okugawa K, Fujiwara N, Yamashita T, Fujiki H, Harada S, Yoshimura T and Yamagisi H: Streptococcal preparation OK-432 promotes functional maturation of human monocyte-derived dendritic cells. Cancer Immunol Immunother 52: 207-214, 2003.
16. Nakahara S, Tsunoda T, Baba T, Asabe S and Tahara H: Dendritic cells stimulated with a bacterial product, OK-432, efficiently induce cytotoxic T lymphocytes specific to tumor rejection peptide. Cancer Res 63: 4112-4118, 2003.
17. Kuroki H, Morisaki T, Matsumoto K, Onishi H, Baba E, Tanaka M and Katano M: Streptococcal preparation OK-432: a new maturation factor of monocyte-derived dendritic cells for clinical use. Cancer Immunol Immunother 52: 561-568, 2003.
18. Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA: The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86: 973-983, 1996.
19. Aderem A and Ulevitch RJ: Toll-like receptors in the induction of the innate immune response. Nature 406: 782-787, 2000.
20. Medzhitov R, Preston-Hurlburt P and Janeway CA Jr: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397, 1997.
21. Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, Bazan F and Liu YJ: Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 194: 863-869, 2001.
22. Re F and Strominger JL: Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem 276: 37692-37699, 2001.
23. Romani N, Gruner S, Brang D, Kampgen E, Lenz A, Trockenbacher B, Konwalinka G, Fritsch PO, Steinman RM and Schuler G: Proliferating dendritic cell progenitors in human blood. J Exp Med 180: 83-93, 1994.
24. Sallusto F, Cella M, Danieli C and Lanzavecchia A: Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 182: 389-400, 1995.
25. Arrighi JF, Rebsamen M, Rousset F, Kindler V and Hauser C: A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers. J Immunol 166: 3837-3845, 2001.
26. Rescigno M, Martino M, Sutherland CL, Gold MR and Ricciardi-Castagnoli P: Dendritic cell survival and maturation are regulated by different signaling pathways. J Exp Med 188: 2175-2180, 1998.
27. Okamoto M, Oshikawa T, Tano T, Ohe G, Furuichi S, Nishikawa H, Ahmed SU, Akashi S, Miyake K, Takeuchi O, Akira S, Moriya Y, MatsubaraS, Ryoma Y, Saito M and Sato M: Involvement of Toll-like receptor 4 signaling in interferon-gamma production and antitumor effect by streptococcal agent OK-432. J Natl Cancer Inst 95: 316-326, 2003.
28. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL and Schwartz DA: TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25: 187-191, 2000.
29. Hoffmann JA, Kafatos FC, Janeway CA and Ezekowitz RAB: Phylogenetic perspectives in innate immunity. Science 284: 1313-1318, 1999.
30. Okamoto M, Oshikawa T, Ohe G, Nishikawa H, Furuichi S, Tano T, Moriya Y, Saito M and Sato M: Severe impairment of anti-cancer effect of lipoteichoic acid-related molecule isolated from a penicillin-killed Streptococcus pyogenes in toll-like receptor 4-deficient mice. Int Immunopharmacol 1: 1789-1795, 2001.
31. Picard C, Puel A, Bonnet M, Ku CL, Bytamante J, Yang K, Soudais C, Dupuis S, Feinberg J, Fieschi C, Elbim C, Hitghcock R, Lammas D, Davies G, Ghonaium AA, Rayes HA, Jumaah SA, Hajjar SA, Mohsen IZA, Frayha HH, Rucker R, Hawn TR, Aderem A, Tufenkeji H, Haraguchi S, Day NK, Good RA, Pocidalo MAG, Ozinsky A and Casanova JL: Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299: 2076-2079, 2003.